Delivery Order SPE2DB20D1100-SPE2DB25FA1C8

Award Date 1/16/25
Potential Completion Date 2/7/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,100.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Pfizer COVID-19 vaccine doses to support healthcare requirements from 2024 to 2025, including an initial 6-month period and up to a 4-year extension. This order is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.9 ML Pfizer COVID-19 vaccines from 2024-2025. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $1,092.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines and related medical commodities. The award is part of a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a $4,702.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Pfizer COVID-19 vaccines, with a period of performance through December 10, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $4,866.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Pfizer COVID-19 vaccines with a delivery period from 2024 to 2025. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a $21,841.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 0.9ML Pfizer COVID-19 vaccines for the 2024-2025 time period under an Existing Use Authorization (EUA). The contract has an ultimate completion date of September 11, 2024. It is not designated as a set-aside contract. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $1,622.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the procurement of Pfizer COVID-19 vaccines, with a period of performance from January 2024 to January 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,355.84 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, for the supply of 0.9 ml COVID-19 vaccines from Pfizer for the period of March 2023 to March 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00, to provide a wide range of...
This is a $1,081.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines with a period of performance from January 2023 to January 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with an ultimate completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA1C8
    Delivery Order

This is a $3,389.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 0.9 ml Pfizer COVID-19 vaccine doses between 2024 and 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition. The contract supports the federal government's efforts to ensure the continued availability of critical COVID-19 vaccines for military personnel, veterans, and other federal beneficiaries.

Generated 4/18/25, 2:06 AM